Abstract
Epithelial cells are subject to significant mechanical stress and therefore require a structure to protect them from permanent damage. This structure is the cytoskeleton and it is formed by three classes of proteins: microfilaments (principally actin), microtubules (principally tubulin), and intermediate filaments (IFs) (Steinert and Roop, 1988). The IF proteins differ from the actin and tubulin proteins in several important ways. The IFs are a highly diverse family of proteins. In contrast, there are only approximately 6 forms of actin and six forms each of the 2 types of tubulin (α and,β). IF proteins are non-polar, elongated molecules. In contrast, the actin and tubulin proteins are polar and globular molecules. The sizes of the cytoskeletal proteins range from 6 nm (actin) and 10 nm (IFs) to 23 nm (tubulin).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abe M and Oshima RG (1990) A single human keratin K18 gene is expressed in diverse epithelial cells of transgenic mice. J Cell Biol 1 l 1: 1197–1206.
Adams JC and Watt FM (1989) Fibronectin inhibits the terminal differentiation of human keratinocytes. Nature 340: 307–309.
Agura ED, Howard M and Collins SJ (1992) Identification and sequence analysis of the promoter for the leukocyte integrin beta-subunit (CD 18): A retinoic acid-inducible gene. Blood 79: 602–609.
Akiyama SK, Olden K and Yamada KM (1995) Fibronectin and integrins in invasion and metastasis. Can Metas Rev 14: 71–189.
Albelda SM, Mette SA, Elder DA, Stewart R, Damjanovich L, Herlyn M and Buck CA (1990) Integrin distribution in malignant melanoma: association of the ß3 subunit with tumor progression. Cancer Res 50: 6757–66764.
Albelda S (1993) Role of integrins and other cell adhesion molecules in tumor progression and metastasis. Laboratory Investigation 68 (I): 4–17.
Anastassiou G, Duensing S, Steinhoff G, Kirchner H, Ganser A and Atzpodien J (1995) In vivo distribution of integrin in renal cell carcinoma: integrin-phenotype alteration in different degrees of tumour differentiation and VLA-2 involvement in tumor metastasis. Cancer Biother 10(4): 287–292.
Anderson JM, Heindl LM, Bauman PA, Ludi CW, Dalton WS and Cress AE (1996) Cytokeratin expression results in a drug-resistant phenotype to six different chemotherapeutic agents. Clin Cancer Res 2: 97–105.
Aoshiba K, Rennard SI and Spurzem JR (1997) Cell-matrix and cell-cell interactions modulate apoptosis of bronchial epithelial cells. Am J Physiol 272: L28 - L37.
Arihiro K, Inai K, Kurihara K, Takada S, Kaneko M, Kuroi and Tog T (1993) Loss of VLA-2 collagen receptor in breast carcinoma, facilitating invasion and metastasis. Jpn J Cancer Res 84: 726–733.
Bauman PA, Dalton WS, Anderson JM and Cress AE (1994) Expression of cytokeratin confers multiple drug resistance. Proc Natl Acad Sci USA 91: 5311–5314.
Ben-Ze’ev A, Zöller M and Raz A (1986) Differential expression of intermediate filament proteins in metastatic and nonmetastatic variants of the BSp73 tumour. Cancer Res 46: 785–790.
Bernstein ML, Leclerc JM, Bunin G, Brisson L, Robison L, Shuster J, Byrne T, Bregory D, Hill G, Dougherty G, Scriver C, Lemieux B, Tuchman M and Woods WG (1992) A population-based study of the neuroblastoma incidence, survival, and mortality in North America. J Clin Oncol 10: 323–329.
Biedler JL, Casals D, Chang TD, Meyers MB, Spengler BA and Ross RA (1991) Multi-drug resistant human neuroblastoma cells are more differentiated than controls and retinoic acid further induces lineage-specific differentiation. In: Evans AE, D’Angio GJ, Knudson AG and Seeger RC (eds) Advances in neuroblastoma research, New York, Wiley-Liss, pp. 181–191.
Birkenmeier TM, McQuillan JJ, Boedeker ED, Argraves WS, Rouslahti E and Dean DC (1991) The alpha 5 beta 1 fibronectin receptor. Characterisation of the alpha 5 gene promoter. J Biol Chem 266: 20544–20549.
Bisgaard HC, Ton PT, Nagy P and Thorgeirsson SS (1994) Phenotypic modulation of keratins, vimentin and a-fetoprotein in cultured rat liver epithelial cells after chemical, oncogene, and spontaneous transformation. J Cell Physiol 159: 485–494.
Blackwell TK, Huang J, Ma A, Kretzner L, Alt FW, Eisenman RN and Weintraub H (1993) Mol Cell Biol 13: 5216–5224.
Blouin R, Swierenga SHM and Marceau N (1992) Evidence for post-transcriptional regulation of cytokeratin gene expression in a rat liver epithelial cell line. Biochem Cell Biol 70: 1–9.
Blumenberg M (1988) Concerted gene duplications in the two keratin gene families. J Mol Evol 27: 203–211.
Boudreau N, Sympson CJ, Werb Z and Bissell MI (1995) Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science 267: 891–893.
Briesewitz R, Epstein MR and Marcantonio EE (1993) Expression of native and truncated forms of the human integrin al subunit. J Biol Chem 268 (4): 2989–2996.
Brooks PC, Montgomery AMP, Rosenfeld M, Eisfeld RA, Hu T, Klier G and Cheresch DA (1994) Integrin au/33 antagonists promote tumour regression by inducing apoptosis of angiogenic blood vessels. Cell 79: 1157–1164.
Buck CA and Horwitz AF (1987) Cell surface receptors for extra- cellular matrix molecules. Annu Rev Cell Biol 3: 179–205.
Casanova L, Bravo A, Were F, Ramirez A, Jorcano JJ and Vidal M (1995) Tissue-specific and efficient expression of the human simple epithelial keratin 8 gene in transgenic mice. J Cell Biol 108: 811–820.
Ceratto N, Dobkin C, Carter M, Jenkins E, Yao XL, Cassiman JJ, Aly MS, Bosco P, Leube R, Langbein L, Feo S and Romano V (1997) Human type I cytokeratin genes are a compact cluster. Cytogenet Cell Genet 77: 169–174.
Cervella P, Silengo L, Pastore C and Altruda F (1993) Human ß t -integrin gene expression is regulated by two promoter regions. J Biol Chem 268 (7): 5148–5155.
Chan BMC, Matsuura N, Takada Y, Zetter BR and Hemler ME (1991) In vitro and in vivo consequences of VLA-2 expression of rhabdomyosarcoma cells. Science 251: 1600–1602.
Chen F-A, Alosco T, Croy BA, Narumi K, Percy DH and Bankert RB (1994a) Clones of tumour cells derived from a single primary human lung tumour reveal different patterns of Si integrin expression. Cell Adhes Comm 2: 345–357.
Chen H-C, Kinch MS, Lin TH, Nurridge K and Juliano RL (1994b) Integrin mediated cell adhesion activates mitogen activated protein kinases. J Biol Chem 269: 26602–26605.
Chintala SK, Sawaya R, Gokaslan ZL and Rao JS (1996) Modulation of matrix metalloprotease-2 and invasion in human glioma cells by a3 integrin. Can Lett 103: 201–208.
Chu Y-W, Runyan R, Oshima RG and Hendrix MJC (1993) Expression of complete keratin filaments in mouse L cells augments cell migration and invasion. Proc Natl Acad Sci USA 90: 4261–4265.
Chu Y-W, Seftor EA, Romer LH, Hendrix MJC (1996) Experimental coexpression of vimentin and keratin intermediate filaments in human melanoma cells augments motility. Am J Pathol 148: 63–69.
Clark EA and Brugge JS (1995) Integrins and signal transduction pathways: the road taken. Science 268, 233–239.
Clarke AS, Lotz MM, Chao C and Mercurio AM (1995) Activation of the p21 pathway of growth arrest and apoptosis by the beta (4) integrin cytoplasmic domain. J Biol Chem 270, 22673–22676.
Clarke MR, Landreneau RJ, Finkelstein SJ, Wu TT, Ohori P and Yousem SA (1997) Extracellular matrix expression in metastasizing and nonmetastasizing adenocarcinomas of the lung. Hum Pathol 27 (1): 54–59.
Corbi AL and Lopez-Rodriguez C (1997) CDI Ic integrin gene promoter activity during myeloid differentiation. Leuk Lymph 25: 415–425.
Conforti G, Codegoni AM, Scanziani E, Dolfini E, Dasdia T, Calza M, Caniatti M and Broggini M (1995) Different vimentin expression in two clones derived from a human colon carcinoma cell line ( LoVo) showing different sensitivity to doxorubicin. Br J Cancer 71: 505–511.
Cremisi C and Duprey P (1989) A labile inhibitor blocks endo A gene transcription in murine undifferentiated embryonal carcinoma cells. Nuc Acids Res 15: 6105–6116.
Cress AE and Dalton WS (1996) Multiple drug resistance and intermediate filaments. Can Metas Rev 15: 499–506.
Damjanovich L, Albelda SM, Mette SA and Buck CA (1992) Distribution of integrin cell adhesion receptors in normal and malignant lung tissue. Am J Respir Cell Mol Biol 6: 197–206.
Danen EHJ, Jansen KFJ, Van Kraats AA, Cornelissen IMHA, Ruiter DJ and Van Muijen, GNP (1995a) a, integrins in human melanoma: Gain of a„133and loss of a„ß5 are related to tumour progression in situ but not to metastatic capacity of cell lines in nude mice. Int J Can 61: 491–496.
Danen EHJ, Van Muijen GNP and Ruiter DJ (1995b) Role of integrins as signal transducing cell adhesion molecules in human cutaneous melanoma. Cancer Surveys 24, 43–65.
Daniel JL, Dangelmaier C and Smith JB (1992) Evidence for a role for tyrosine phosphorylation of phospholipase Cy2 in collagen induced platelet cytosolic mobilisation. Biochem J 302: 617–622.
D’Ardenne AJ, Richman PI, Horton MA, Mcaulay AE and Jordan S (1991) Co-ordinate expression of alpha-6 integrin laminin receptor sub-unit and laminin in breast cancer. J Pathol 165: 213–220.
Darmon M (1985) Coexpression of specific acid and basic cytokeratins in teratocarcinoma-derived fibroblasts treated with 5-azacytidine. Dev Biol 110: 47–52.
Davis RJ (1993) The mitogen-activated protein kinase signal transduction pathway. J Biol Chem 269: 26602–26605.
Day ML, Foster RG, Day KC, Zhao X, Humphrey P, Swanson P, Postigo AA, Zhang SH and Dean DC (1997) Cell anchorage regulates apoptosis through the retinoblastoma tumour suppressor/E2F pathway. J Biol Chem 272 (13): 125–8128.
Dedhar S and Hannigan GE (1996) Integrin cytoplasmic interactions and bidirectional transmembrane signalling. Curr Opin Cell Biol 8: 657–669.
Defilippi P, Bozzo C, Volpe G, Romano G, Venturino M, Silengo L and Tarnone G (1994) Integrin-mediated signal transduction in human endothelial cells: analysis of tyrosine phosphorylation events. Cell Adhes Commun 2: 75–86.
Deuel TF, Kawahara RS, Mustoe TA and Pierce GF (1991) Growth factors and wound healing-platelet-derived growth factor as a model cytokine. Annu Rev Med 42: 567–584.
Dodemont H, Reimer D and Weber K (1990) Structure of an invertebrate gene encoding cytoplasmic intermediate filament (IF) proteins: implications for the origin and the diversification of IF proteins. EMBO 9: 4083–4094.
Döring V and Stick R (1990) Gene Structure of nuclear lamin LIII of Xenopus laevis: a model for the evolution of IF proteins from a lamin-like ancestor. EMBO 9: 4073–4081.
Duensing S, Nunez FB, Meyer N, Anastassiou G, Nasarek A, Grosse J, Buer J, Probst M, Ganser A and Atzpodien J (1996) Exposure to vinblastine modulates ß 1 integrin expression and in vitro binding to extracellular matrix molecules in a human renal carcinoma cell line. Invasion Metas 16: 65–72.
Elices MJ, Osborn L, Takada Y, Crouse C, Lubkowski S, Hemler ME and Lobb RR (1990) VCAM-1 on activated endothelium interacts with the leucocyte integrin VLA-4 at a site distinct from the VLA/fibronectin binding site. Cell 60: 577–584.
Fässler R, George-Labouesse E and Hirsch E (1996) Genetic analysis of integrin function in mice. Curr Opin Cell Biol 8: 641–646.
Feldman LE, Shin KC, Natale RB and Todd R (1991) Beta 1 integrin expression on human small cell lung cancer cells. Cancer Res 51: 1065–1070.
Ferrell JE and Martin GS (1989) Tyrosine-specific protein phosphorylation is regulated by glycoprotein IIls-Ilia in platelets. Proc Natl Acad Sci USA 86: 2234–2238.
Francy AJM, Van de Klundert J, Raats MH and Bloemendahl H (1993) Intermediate filaments: regulation of gene expression and assembly. Eur J Biochem 214: 351–366.
Frisch SM and Francis H (1994) Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 124: 619–626.
Fuchs E (1988) Keratins as biochemical markers of epithelial differentiation. Trends Genet 4: 277–281.
Fujii K (1996) Ligand activation of overexpressed epidermal growth factor receptor results in loss of epithelial phenotype and impaired RGD-sensitive integrin function in HSC-1 cells. J Invest Dermatol 107 (2): 195–202.
Fujimura Y, Yamamoto H, Hamazato F and Nozaki M (1994) One of the two Ets-binding sites in the cytokeratin EndoA enhancer is essential for enhancer activity and binds to Ets-2 related proteins. Nuc Acids Res 22: 613–618.
Gailit J and Clark RAF (1994) Wound repair in the context of extracellular matrix. Curr Opin Cell Biol 6: 717–725.
Giancotti F and Ruoslahti E (1990) Elevated levels of the a5ß1 fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells. Cell 60: 849–859.
Gong J, Wang D, Sun L, Zborowska E, Willson JKV and Brattain Mg (1997) Role of 050 1 integrin in determining the malignant properties of colon carcinoma cells. Cell Growth Diff 8: 83–90.
Guadango TM, Ohstubo M, Roberts JM and Assoian RK (1993) A link between cyclin A expression and adhesion-dependent cell cycle proliferation. Science 262: 1572–1575.
Gumbiner BM (1996) Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 84: 345–357.
Hafez MM, Hsu S, Yan Z, Winawer S and Friedman E (1992) Two roles for transforming growth factor 01 in colon enterocytic cell differentiation. Cell Growth Diff 3: 753–762.
Heino J (1996) Biology of tumour cell invasion: interplay of cell adhesion and matrix degradation. Int J Cancer 65: 717–722.
Heino J and Massague J (1989) Transforming growth factor-beta switches the pattern of integrins expressed in Mg-63 human oesteosarcoma cells and causes a selective loss of cell adhesion to lamina. J Biol Chem 264: 21806–21811.
Heino J, Ignotz RA, Hemler ME, Crouse C and Massagué J (1989) Regulation of cell adhesion receptors by transforming growth factor-ß. J Biol Chem 264 (1): 380–388.
Hemler ME, Huang C and Schwarz L (1987) The VLA Protein Family. J Biol Chem 262 (7): 3300–3309.
Hendrix MJ, Seftor EA, Chu Y, Seftor REB, Nagle RB, McDaniel KM, Leong SPL, Yohem KH, Leibovitz AM, Meyskens FL, Conaway DH, Welch DR, Liotta LA and Stetler-Stevens M (1992) Coexpression of vimentin and keratins by human melanoma tumor cells: a correlation with invasive and metaplastic potential. J Natl Cancer Inst 84: 165–174.
Hendrix MJC, Seftor EA, Chu Y-W, Trevor KT and Seftor REB (1996) Role of intermediate filaments in migration, invasion and metastasis. Cancer Metas Rev 15: 507–525.
Hendrix MJC, Seftor EA, Seftor REB and Trevor KT (1997) Experimental co-expression of vimentin and keratin intermediate filaments in human breast cancer cells results in phenotypic inter-conversion and increased invasive behavior. Amer J Pathol 150: 483–495.
Hibbs ML, Xu H., Stacker SA and Springer TA (1991) Regulation of adhesion of ICAM-1 by the cytoplasmic domain of LFA-1 integrin ß subunit. Science 251: 1611–1613.
Hickstein DD, Baker DM, Gollahon KA and Back AL (1992) Identification of the promoter of the myelomonocytic leukocyte integrin CD1 Ib. Proc Natl Acad Sci USA 89: 2105–2109.
Hillis GS and MacLeod AM (1996) Integrins and disease. Clin Sci 91: 639–650.
Horwitz A (1997) Integrins and Health. Scientific American May: 46–53.
Howlett AR, Bailey N, Damsky C, Peterson OW and Bissell M (1995) Cellular growth and survival are mediated by ß 1 integrins in normal human breast epithelium but not in breast carcinoma. J Cell Sci 108: 1945–1957.
Humphries MJ (1990) The molecular basis and specificity of integrin-ligand interactions. J Cell Sci 97: 585–592.
Hynes RO (I 987) Integrins: A family of cell surface receptors. Cell 48: 549–554.
Ichinose Y, Morita T, Zhang F, Srimahasongcram S, Tondella MLC, Matsumoto M, Nozaki M and Matsushiro A (1988) Nucleotide sequence and structure of the mouse cytokeratin endoB gene. Gene 70: 85–95.
Ignatius MJ, Large TH, Houde M, Tawil JW, Barton A, Esch F, Carbonetta S and Reichardt LF (1990) Molecular cloning of the rat integrin a 1-subunit: A receptor for laminin and collagen. J Cell Biol 111: 709–720.
Ignotz RA, Heino J and Massague J (1989) Regulation of cell adhesion receptors by transforming growth factor-ß. J Biol Chem 264 (1): 389–392.
Jackson BW, Grund C, Schmid E, Burki K, Franke WW and Illmensee K (1980) Formation of cytoskeletal elements during mouse embryogenesis. Intermediate filaments of the cytokeratin type and desmosomes in preimplantation embryos. Differentiation 17: 161–179.
Jensen PJ and Wheelock MJ (1996) The relationships among adhesion, stratification and differentiation in keratinocytes. Cell Death Diff 3: 357–371.
Jones PH and Watt FM (1993) Separation of human epidermal stem cells from transit amplifying cells on the basis of differences in integrin function and expression. Cell 73: 713–724.
Jones PH, Harper S and Watt FM (1995) Stem cell patterning and fate in human epidermis. Cell 80: 83–93.
Judware R and Culp LA (1997a) Concomitant down-regulation of integrin subunits by N-myc in human neurobastoma cells: differential regulation of a2, a3 and ßl. Oncogene 14: 1341–1350.
Judware R and Culp LA (1997b) N-myc over-expression downregulates a3ß1 integrin expression in human Saos-2 osteosarcoma cells. Clin Exp Metastasis 15: 228–238.
Kanner SB, Grosmaire LS, Ledbetter JA and Damle NK (1993) ß2-integrin LFA-I signalling through phospholipase C-y 1 activation. Proc Natl Acad Sci USA 90: 7099–7103.
Kapron-Bras C, Fitz-Gibbon L, Jeevaratnam P, Wilkins J and Dedhar S (1993) Integrin clustering stimulates p21 ras activation. J Biol Chem 268: 20701–20704.
Kassner PD, Kawaguchi S and Hemler ME (1994) Minimum a chain cytoplastic tail sequence needed to support integrinmediated adhesion. J Biol Chem 269: 19859–19867.
Katabami M, Fujita H, Honke K, Makita A, Akita H, Miyamoto H, Kawakami Y and kuzumaki N (1993) Marked reduction of type I keratin (K14) in cisplatin-resistant human lung squamouscarcinoma cell lines. Biochem Pharm 45: 1703–1710.
Keely PJ, Fong AM, Zutter MM and Santoro SA (1995) Alternation of collagen-dependant adhesion motility and morphogensis by the expression of antisense a2 integrin mRNA in mammary cells. J Cell Sci 108: 595–607.
Khawja A, Rodriguez-Viciana P, Wennström S, Warne PH and Downward J (1997) Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein B/Akt cellular survival pathway. EMBO J 16 (10): 2783–2793.
Kim LT and Yamada KY (1997) The regulation of expression of integrin receptors. Proc Soc Exp Biol Med 214 (2): 123–131.
Kirchhofer D, Languino LR, Ruoslahti E and Pierschbacher MD (1990) a2ß1 integrins from different cell types show different binding specificities. J Biol Chem 265: 615–618.
Klein CE, Dresel D, Steinmayer T, Mauch C, Eckes B, Krieg T, Bankert RB and Weber L (1991) Integrin a2ß1 is upregulated in fibroblasts and highly agressive melanoma cells in three-dimensional collagen lattices and mediates the reorganization of collagen I fibrils. J Cell Biol 115: 1427–1436.
Klemz MJ, McKercher SR, Celada A, Van Beveren C and Maki RA (1990) The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene. Cell 61: 113–124.
Knapp AC and Franke WW (1989) Spontaneous losses of control of cytokeratin gene expression in transformed, non-epithelial human cells occurring at different levels of regulation. Cell 59: 67–79.
Knox JD, Cress AE, Clark V, Manquez L, Affinito KS, Dalkin BL and Nagle RB (1994) Differential expression of extracellular matrix molecules and the alpha 6-integrins in the normal and neoplastic prostate. Am J Pathol 145: 167–174.
Koretz K, Schlag P, Boumsell L and Möller P (1991) Expression of VLA-a2, VLA-a6, and VLA-ßl chains in normal mucosa and adenomas of the colon, and in colon carcinomas and their liver metastases. Am J Pathol 138 (3): 741–750.
Korhonen M, Laitinen L, Ylänne J, Koukoulis GK, Quaranta V, Juusela H, Gould VE and Virtanen I (1992) Integrin distributions in renal cell carcinomas of various grades of malignancy. Am J Pathol 141 (5): 1161–1171.
Kornberg U, Earp HS, Turner CE, Prockop C and Juliano RL (1991) Signal transduction by integrins: increased tyrosine phosphorylation caused by clustering of 131 integrins. Proc Natl Acad Sci USA 88: 8392–8396.
Kosmehl H, Berndt A, Katenkamp D, Hyckel P, Stiller KJ, Gabler U, Langbein L and Reh T (1995) Integrin receptors and their relationship to cellular proliferation and differentiation of oral squamous cell carcinoma. A quantitative immunohistochemical study. J Oral Pathol Med 24: 343–348.
Koukoulis GK, Virtanen I, Korhonen M, Laitinen L, Quaranta V and Gould VE (1991) Immunohistochemical localisation of integrins in the normal, hyperplastic, and neoplastic breast. Am J Pathol 139: 787–799.
Koukoulis GK, Virtanen I, Moll R, Quaranta V and Gould VE (1993) lmmunolocalisation of integrins in the normal and neo-plastic colon epithelium. Virchows Archivs 63: 373–383.
Krauss S and Franke WW (1990) Organization and sequence of the human gene encoding cytokeratin 8. Gene 86: 241–249.
Kulesh DA and Oshima RG (1988) Cloning of the human keratin 18 gene and its expression in nonepithelial mouse cells. Mol Cell Biol 8: 1540–1550.
Kulesh DA, Cecena G, Darmon YM, Vasseur M and Oshima RG (1989) Posttranslational regulation of keratins: degradation of mouse and human keratins 18 and 8. Mol Cell Biol 9: 1553–1565.
Kulesh DA and Oshima RG (1989) Complete structure of the gene for human keratin 18 gene. Genomics 4: 339–347.
Kumar NM, Sigurdson SL, Sheppard D and Lwebuga-Mukasa JS (1995) Differential modulation of integrin receptors and extra-
cellular matrix laminin by transforming growth factor-pi in rat alveolar epithelial cells. Exp Cell Res 221: 385–394.
LaFlamme SE and Auer KL (1996) Integrin signalling. Stem Cell Biol 7: 111–118.
LaFlamme SE, Akiyama SK and Yamada KM (1992) Regulation of fibronectin receptor distribution. J Cell Biol 124: 1047–1059.
Leask A, Rosenberg M, Vassar R and Fuchs E (1990) Regulation of a human epidermal keratin gene: sequences and nuclear factors involved in keratinocyte-specific transcription. Genes Dev 4: 1985–1988.
Ledinko N and Costantino RL (1990) Modulation of p53 gene expression and cytokeratin 18 in retinoid-mediated invasion suppressed lung carcinoma cells. Anticancer Res 10: 1335–1339.
Liao J, Lowthert LA, Ghori N and Omary MB (1995) The 70kDa heat shock proteins associate with glandular intermediate filaments in an ATP-dependent manner. J Biol Chem 270: 915–922.
Liao J and Omary MB (1995) 14–3–3 proteins associate with phosphorylated simple epithelial keratins during cell cycle progression and act as a solubility cofactor. J Cell Biol 133: 345–357.
Lin C-S, Chen Y, Huynh T and Kramer R (1997) Identification of the human a6 gene promoter. DNA Cell Biol 16 (8): 929–937.
Lin C-S, Zhang K and Kramer R (1993) a6 integrin is up-regulated in step-increments accompanying neoplastic transformation and tumorigenic conversion of human fibroblasts. Cancer Res 53: 2950–2953.
Lin TH, Yurochko A, Komberg L, Morris J, Walker Ti, Haskill S and Juliano R (1994) The role of protein tyrosine phosphorylation in integrin-mediated gene induction in monocytes. J Cell Biol 126: 1585–1593.
Liotta LA (1986) Tumour invasion and metastasis: role of extracellular matrix. Cancer Res 46: 1–7.
Loeser RF (1997) Growth factor regulation of chondrocyte integrins. Arthritus Rheum 40 (2): 270–276.
Lopez-Rodriguez C and Corbi AL (1997) PU.1 negatively regulates the CD1 lc integrin gene promoter through recognition of the major transcriptional start site. Eur J Immunol 27: 1843–1847.
Lopez-Rodriguez C, Zubiaur M, Sancho J, Concha A and Corbi AL (1997) An octamer element functions as a regulatory element in the differentiation-responsive CD1lc integrin gene reporter. J Immunol 158: 5833–5840.
McGill G, Shimamura A, Bates RC, Savage RE and Fisher DE (1997) Loss of matrix adhesion triggers rapid transformation-selective apoptosis in fibroblasts. J Cell Biol 138 (4): 901–911.
Meredith J, Takada Y, Fornaro M, Languino LR and Schwartz MA (1995) Inhibition of cell cycle progression by the alternatively spliced integrin ß 1C. Science 269: 1570–1572.
Miao J-Y, Araki S, Kaji K and Hayashi H (1997) Integrin ß4 is involved in apoptotic signal transduction in endothelial cells. Biochem Biophys Res Comm 233: 182–186.
Miyashita T, Yamamoto H, Takemoto Y, Nozaki M, Morita T and Matushiro A (1993) Identification of differentiation-dependent DNase-I hypersensitive sites in the mouse EndoA gene. Gene 125: 151–158.
Moll R, Franke WW, Schiller DL, Geiger B and Krepler R (1982) The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 31: 11–24.
Moran E, Cleary I, Larkin AM, Nic Amhlaoibh R, Masterson A, Scheper RJ, Izquierdo MA, Center M, O’Sullivan F and Clynes M (1997) Co-expression of MDR-associated markers, including p-170, MRP and LRP and cytoskeletal proteins, in three resistant variants of the human ovarian carcinoma cell line, OAW42. Eur J Cancer 33: 652–660.
Morino N, Minura T, Hamasaki K, Tobe K, Ueki K, Kikuchi K, Takehara K, Kadowaki T, Yazaki Y and Nojima Y (1995) Matrix/integrin interaction activates the mitogen-activated protein kinases, p44erk-1 and p42erk-2. J Biol Chem 270: 269–273.
Morita T, Tondella MLC, Takemoto Y, Hashido K, Ichinose Y, Nozaki M and Matsushiro A (1988) Nucleotide sequence of mouse EndoA cytokeratin cDNA reveals polypeptide characteristics of the type-II keratin subfamily. Gene 68: 109–117.
Mortarini R, Anichini A and Parmiani G (1991) Heterogeneity for integrin expression and cytokine-mediated VLA modulation can influence the adhesion of human melanoma cells to extracellular matrix proteins. Int J Cancer 47: 551–559.
Mukhopadhyay T and Roth JA (1996a) p53 involvement in activation of the cytokeratin 8 gene in tumor cell lines. Anticanc Res 16: 105–112.
Mukhopadhyay T and Roth JA (1996b) Functional inactivation of p53 by antisense RNA induces invasive ability of lung carcinoma cells and downregulates cytokeratin synthesis. Anticanc Res 16: 1683–1690.
Narita T, Kawakami-Kimura N, Sato M, Matsuura N, Higashiyama S, Taniguchi N and Kannagi R (1996) Alteration of integrins by heparin-binding EGF-like growth factor in human breast cancer cells. Oncology 53: 374–381.
Natali PG, Hamby CV, Felding-Habermann B, Liamg L, Nicotra MR, Di Filippo F, Giannarelli D, Temponi M and Ferrone S (1997) Clinical significance of a„ß3 integrin and intercellular adhesion molecule-1 expression in cutaneous malignant melanoma lesions. Cancer Res 57: 1554–1560.
Newham P and Humphries MJ (1996) Integrin adhesion receptors: structure, function and implications for biomedicine. Molecular Medecine Today July: 304–313.
Neznanov NS and Oshima RG (1993) cis regulation of the keratin 18 gene in transgenic mice. Mol Cell Biol 13: 1815–1823.
Neznanov NS, Umezawa A and Oshima RG (1997) A regulatory element within a coding exon modulates keratin 18 gene expression in transgenic mice. J Biol Chem 272: 27549–27557.
Nigam AK, Savage FJ, Boulos PB, Stamp GWH, Liu D and Pignatelli M (1993) Loss of cell-cell and cell-matrix adhesion molecules in colorectal cancer. Br J Cancer 68: 507–514.
Nista A, Leonetti C, Bernardini G, Mattioni M and Santoni A (1997) Functional role of a4ß1 and a5ß1 integrin fibronectin receptors expressed on adriamycin-resistant MCF-7 human mammary carcinoma cells. Int J Cancer 72: 133–141.
Nista A, Mattioni M, Gismondi A, Palmieri G and Santoni A (1996) ß1-integrin expression and function in human bladder cancer cells: modulation by TNFa. Anticancer Res 16: 581–588.
Omary MB, Baxter GT, Chou C-F, Riopel CL, Lin WY and Strulovici B (1992) PKCe-related kinase associates with and phosphorylates cytokeratin 8 and 18. J Cell Biol 117: 583–593.
Onclerq R, Lavenu A and Cremisi C (1989) Pleitropic derepression of developmentally regulated cellular and viral genes by c-myc protooncogene products in undifferentiated embryonal carcinoma cells. Nuc Acids Res 17: 735–753.
Oshima RG, Milian JL and Cecena G (1986) Comparison of mouse and human keratin 18: a component of intermediate filaments expressed prior to implantation. Differentiation 33: 61–68.
Oshima RG, Trevor K, Shevinsky LH, Ryder OA and Cecena (1988) Identification of the gene coding for the Endo B murine cytokeratin and its methylated, stable inactive state in mouse nonepithelial cells. Genes Dev 2: 505–516.
Oshima RG, Abrams L and Kulesh D (1990) Activation of an intron enhancer within the keratin 18 gene by expression of c-fos and c-jun in undifferentiated F9 embryonal carcinoma cells. Genes Dev 4: 835–848.
Oshima RG, Baribault H and Caulin C (1996) Oncogenic regulation and function of keratins 8 and K18. Cancer Metas Rev 15: 445471.
O’Toole TE, Katagiri Y, Faull RI, Peter K, Kamura R, Quaranta V, Loftus JC, Shattil SJ and Ginsberg MH (1994) Integrin cytoplasmic domains mediate inside-out signal transduction. J Cell Biol 124: 1047–1059.
Pahl HL, Scheibe RJ, Zhang DE, Chen HM, Galson DL, Maki RA and Tenen DG (1993) The proto-oncogene PU.1 regulates the expression of the myeloid-specific CD1lb promoter. J Biol Chem 268: 5014–5020.
Paine ML, Gibbins JR, Chew KE, Demetriou A Kefford RF (1992) Loss of keratin expression in anaplastic carcinoma cells due to posttranscriptional down-regulation acting in-trans. Cancer Res 52: 6603–6611.
Pankov R, Neznanov N, Umezawa A and Oshima RG (1994a) AP-1, ETS, and transcriptional silencers regulate retinoic acid-dependent induction of keratin 18 in embryonic cells. Mol Cell Biol 14: 7744–7757.
Pankov R, Umezawa A, Maki R, Der CJ, Hauser CA and Oshima RG (1994b) Oncogene activation of human keratin 18 transcription via the Ras signal transduction pathway. Proc Natl Acad Sci USA 91: 873–877.
Pankov R, Simcha 1, Zoller M, Oshima RG and Ben-Ze’ev A (1997) Contrasting effects of K8 and K18 on stabilizing K19 expression, cell motility and tumorgenicity in the BSp73 adenocarcinoma. J Cell Science 110: 965–974.
Parekh HK and Simpkins H (1995) The differential expression of cytokeratin 18 in cisplatin-sensitive and -resistant human ovarian adenocarcinoma cells and its association with drug sensitivity. Cancer Res 55: 5203–5206.
Parekh H and Simpkins H (1996) Cross-resistance and collateral sensitivity to natural product drugs in cisplatin-sensitive and -resistant rat lymphoma and human ovarian carcinoma cells. Cancer Chemother Pharmacol 37: 457–462.
Parsons JT (1996) Integrin-mediated signalling: regulation by protein tyrosine kinases and small GTP-binding proteins. Curr Opin Cell Biol 8: 146–152.
Pasqualini R and Hemler ME (1994) Contrasting roles for integrin ß and ß5 cytoplasmic domains in subcellular localisation, cell proliferation, and cell migration. J Cell Biol 125: 447–460.
Pellegrini R, Martignone S, Ménard S and Ines Colnagh M (1994) Laminin receptor expression and function in small-cell lung carcinoma. Int J Cancer Supplement 8: 116–120.
Perrottin D, Cimino L, Falcioni R, Tibursi G, Gentileschi MP and Sacchi A (1990) Metastatic phenotype growth factor dependence and integrin expression. Anticancer Res 10: 1587–1597.
Pignatelli M and Stamp S (1995) lntegrins in tumour development and spread. Cancer Surveys 24: 113–127.
Pignatelli M and Vessey CJ (1994) Adhesion molecules: novel molecular tools in tumor pathology. Hum Pathol 25: 849–856.
Pignatelli M, Cardillo MR, Hanby A and Stamp GWH (1992) Integrins and their accessory adhesion molecules in mammary carcinomas. Hum Pathol 23: 1159–1166.
Pignatelli M, Hanby A and Stamp G (1991) Low expression of ßi, a2 and a3 subunits of VLA integrins in malignant mammary tumours. J Pathol 165: 25–32.
Pignatelli M, Smith MEF and Bodmer WF (1990) Low expression of collagen receptors on moderate and poorly differentiated colorectal adenocarcinomas. Br J Can 61: 636–638.
Ramaekers FCS, Haag D, Kant A, Moesker O, Jap PHK and Vooijs GP (1983) Coexpression of keratin-and vimentin-type intermediate filaments in human metastatic carcinoma cells. Proc Natl Acad Sci USA 80: 2618–2622.
Re F, Zanetti A, Siron M, Polentarutti N, Lanfrancone L, Dejana E and Colotta F (1994) Inhibition of anchorage-dependant cell spreading triggers apoptosis in cultured endothelial cells. J Cell Biol 127: 537–546.
Ridley At and Hall A (1992) The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 70: 389–399.
Riikoken T, Westermarck J, Koivistro L, Broberg A, Kähäri VM and Heino J (1995) a2ß1 integrin is a positive regulator of collage-nase (MMP-1) and collagen a I (I) gene expression. J Biol Chem 270: 13548–13522.
Rivoltini L, Cattoretti G, Arienti F, Mastroianna A, Melani C, Colombo MP and Parmiani G (1991) The high lysability by LAK cells of colon-carcinoma cells resistant to doxorubicin is associated with a high expression of ICAM-1, LFA-3, NCAM and a less-differentiated phenotype. Int J Cancer 47: 746–754.
Rosen GD, Birkenmeir TM and Dean DC (1991) Characterization of the alpha 4 integrin gene promoter. Proc Natl Acad Sci USA 88: 4094–4098.
Ross SA, Ahrens RA and De Lucia L (1994) Retinoic acid enhances adhesiveness, laminin and integrin ßt synthesis, and retinoic acid receptor expression in F9 teratocarcinoma cells. J Cell Physiol 159: 263–273.
Roussel E, Gingras M-C, Ro JY, Branch C and Roth JA (1994) Loss of a t ß t and reduced expression of other ß t integrin and CAM in lung adenocarcinoma compared with pneumocytes. J Sur Onc 56: 198–208.
Rozzo C, Chiesa V, Carida G, Pagnan G and Ponzoni M (1997) Induction of apoptosis in human neuroblastoma cells by abrogation of integrin-mediated cell adhesion. Int J Cancer 70: 688–698.
Rubartelli A, Poggi A and Zocchi MR (1997) The selective engulfment of apoptotic bodies by dendritic cells is mediated by the avß3 integrin and requires intracellular and extracellular calcium. Eur J Immunol 27: 1893–1900.
Rubio MA, Sotillos M, Jochems G, Alvarez V and Corbi AL (1995) Monocyte activation: rapid induction of al (VLA-1) integrin expression by lipopolysaccharide and interferon-y. Eur J Immunol 25: 2701–2705.
Ruoslahti E and Pierschbacher MD (1987) New perspectives in cell adhesion. Science 283: 491–497.
Ruoslahti E and Reed JC (1994) Anchorage dependence, integrins, and apoptosis. Cell 77: 537–546.
Ruoslahti E (1996) Integrin signalling and matrix assembly. Tumor Biol 17: 117–124.
Ruoslahti E (1997) Integrins as signalling molecules and targets for tumor therapy. Kidney Int 51: 1413–1417.
Sato M, Narita T, Kawakami-Kimura N, Higashiyama S, Taniguchi N, Akiyama S, Hashimoto T, Manabe T and Kannagi R (1996) Increased expression of integrins by heparin-binding EGF like growth factor in human esophageal cancer cells. Cancer Letters 102: 183–191.
Schlaepfer DD, Hanks SK, Hunter T and Van der Geer P (1994) Integrin mediated signal transduction linked to Ras pathway by Grb2 binding to focal adhesion kinase. Nature 372: 786–790.
Schmidhauser C, Casperson GF, Myers CA, Sanzo KT, Bolten S and Bissell MJ (1992) A novel transcriptional enhancer is involved in the prolactin-and extracellular matrix-dependent regulation of beta-casein gene expression. Mol Biol Cell 3: 699–709.
Schreiner C, Fischer M, Hussein S and Juliano RL (1991) Increased tumorigenicity of fibronectin receptor deficient chinese hamster ovary cell variants. Cancer Res 51: 1738–1740.
Schwartz MA, Lechene C and Ingber DE (1991) Insoluble fibronectin activates the Na/H antiporter by clustering and immo-
bilizing integrin a5ß 1,independent of cell shape. Proc Natl Acad Sci USA 88: 7849–7853.
Scott G, Cassidy L and Busacco A (1997) Fibronectin suppresses apoptosis in normal human melanocytes through an integrindependent mechanism. J Invest Dermato] 108: 147–153.
Seftor REB, Seftor EA, Gehilsen KR, Stetler-Stevenson WG, Brown PD, Ruoslahti E and Hendrix MJC (1993) Role of avßl integrin in human melanoma cell invasion. Proc Natl Acad Sci USA 89: 1557–1561.
Serra R, Carbonetto S, Lord M and Isom HC (1994) Transforming growth factor ß t suppresses transformation in hepatocytes by regulating a /31 integrin expression. Cell Growth Diff 5: 509–517.
Seth A, Robinson L, Panayiotakis A, Thompson DM, Hodge DR, Zhang XR, Watson DK, Ozato K and Papas TS (1994) The EndoA enhancer contains multiple ETS binding site repeats and is regulated by ETS proteins. Oncogene 9: 469–477.
Shelley CS and Arnaout MA (1991) The promoter of the CD1lb gene directs myeloid-specific and developmentally regulated expression. Proc Natl Acad Sci USA 88: 10525–10529.
Shen MR, Batzer MA and Deininger PL (1991) Evolution of the master Alu gene(s). J Mol Evol 33: 311–320.
Singer PA, Trevor K and Oshima RG (1986) Molecular cloning of the endoB cytokeratin expressed in preimplantation mouse embryos. J Biol Chem 261: 538–547.
Skalli O and Goldman RD (1991) Recent insights into the assembly, dynamics, and function of intermediate filament networks. Cell Motility Cytoskel 19: 67–79.
Smythe WR, LeBel E, Bavaria JE, Kaiser LR and Albelda SM (1995) Integrin expression in non-small cell carcinoma of the lung. Can Metas Rev 14: 229–239.
Springer TA (1990) Adhesion receptors of the immune system. Nature 346: 425–433.
Staatz WD, Fok KF, Zutter MM, Adams SP, Rodriguez BA and Santoro SA (1991) Identification of a tetrapeptide recognition sequence for the a2ß1 integrin in collagen. J Biol Chem 266: 7363–7367.
Stallmach A, von Lampe B, Matthes H, Bornhoft G and Riecken EO (1992) Diminished expression of integrin adhesion molecules on human colonic epithelial cells during the benign to malignant tumor transformation. Gut. 33: 342–346.
Steinert PM and Roop DR (1988) Molecular and cellular biology ofintermediate filaments. Ann Rev Biochem 57: 593–625.
Steller H (1995) Mechanisms and genes of cellular suicide. Science 267: 145–1449.
Streuli CH, Bailey N and Bissell MJ (1991) Control of mammary epithelial differentiation: basement membrane induces tissue-specific gene expression in the absence of cell-cell interaction and morphological polarity. J Cell Biol 115 (5): 1383–1395.
Su L, Morgan PR and Lane EB (1994) Protein and mRNA expression of simple epithelial keratins in normal, dysplastic, and malignant oral epithelia. Am J Pathol 145: 1349–1357.
Symington BE (1993) Fibronectin receptor modulates cyclin dependent kinase activity. J Biol Chem 268: 21459–21462.
Symington BE and Carter WG (1995) Modulation of epidermal differentiation by epiligrin and integrin a3ßß. J Cell Sci 108: 831–838.
Takada Y and Hemler ME (1989) The primary substructure of the VLA-2/collagen receptor a2 subunit (platelet GPIa): Homology to other integrins and the presence of a possible collagen-binding domain. J Cell Biol 109: 397–407.
Takemoto Y, Fujimura Y, Matsumoto M, Tamai Y, Morita T, Matsushiro A and Nozaki M (1991) The promoter of the endoA gene cytokeratin gene is activated by a 31 downstream enhancer Nuc Acids Res 19: 2761–2765.
Tamai Y, Takemoto Y, Matsumoto M, Morita T, Matsushiro A and Nozaki M (1991) Sequence of the EndoA gene encoding mouse cytokeratin and its methylation state in the CpG-rich region. Gene 104: 169–176.
Tennenbaum PG, Weiner AK, Belanger AJ, Glick AB, Hennings H and Yuspa SH (1993) The suprabasal expression of alpha 6 beta 4 integrin is associated with a high risk of malignant progression in mouse skin carcinogenesis. Cancer Res 53: 4803–4810.
Thomas L, Chan PW, Chang S and Damsky C (1993) 5-Bromo-2deoxyuridine regulates invasiveness and expression of integrins and matrix-degrading proteinases in a differentiated hamster melanoma cell. J Cell Sci 105: 191–201.
Thorey IS, Cecena G, Reynolds and Oshima RG (1993) Alu sequence involvement in transcriptional insulation of the keratin 18 gene in transgenic mice. Mol Cell Biol 13: 6742–6751.
Tyner AL and Fuchs E (1986) Evidence for posttranscriptional regulation of the keratins expressed during hyperproliferation and malignant transformation in human epidermis. J Cell Biol 103: 1945–1955.
Umezawa A, Yamamoto H Rhodes K, Klemsz M, Maki RA and Oshima RG (1997) Methylation of an ETS site in the intron enhancer of the keratin 18 gene participates in tissue-specific repression. Mol Cell Biol 17: 4885–4894.
Ura H, Bonfil RD, Reich R, Reddel R, Pfeifer A, Harris CC and Klein AJP (1989). Expression of type IV collagenase and pro-collagen genes and its correlation with tumorigenic, invasive and metastatic abilities of oncogene-transformed human bronchial epithelial cells. Cancer Res 49: 4615–4621.
Uzan G, Prenant M, Prandini MH, Martin F and Marguerie G (1991) Tissue-specific expression of the platelet GPIIb gene. J Biol Chem 266: 8932–8939.
Vansant G and Reynolds WF (1995) The consensus sequence of a major Alu subfamily contains a functional retinoic acid response element. Proc Nat] Acad Sci USA 92: 8229–8233.
van Valen F, Hanenberg H and Jurgens H (1994) Expression of functional very late antigen-alpha-1, -alpha-2, -alpha-3, and -alpha-6 integrins on Ewing’s sarcoma and primitive peripheral neuroectodermal tumor cells and modulation by interferon-gamma and tumor necrosis factor-alpha. Eur J Can 30A: 2119–2125.
Vasseur M, Duprey P, Brulet P and Jacob F (1985) One gene and one pseudogene for cytokeratin endoA. Proc Natl Acad Sci USA 82: 1155–1159.
Virtanen I, Laitinen A, Tani T, Pääkkö P, Laitinen LA, Burgeson RE and Lehto VP (1996) Differential expression of laminins and their integrin receptors in developing and adult human lung. Am J Respir Cell Mol Biol 15: 184–196.
Volpes R, van den Oord JJ and Desmet VJ (1993) Integrins as differential cell lineage markers of primary liver tumors. Am J Pathol 142: 1483–1492.
Vuori K and Ruoslahti E (1993) Activation of protein kinase C precedes a5ß1 integrin-mediated cell spreading on fibronectin. J Cell Biol 268: 21459–21462.
Waseem A, Alexander CM, Steel JB and Lane EB (1990) Embryonic simple epithelial keratins 8 and 18: chromosomal location emphasizes difference from other keratin pairs. New Biol 2: 464–478.
Weinel Ri, Rosendahl A, Pinschmidt E, Kisker O, Simon B and Santoso S (1995) The alpha 6-integrin receptor in pancreatic carcinomas. Gastronerology 108: 523–532.
Weitzman JB, Hemler ME and Brodt P (1996) Reduction of tumorigenicity by a3 integrin in a rhabdomyosarcoma cell line. Cell Adhes Comm 4: 41–52.
Wu JE and Santoro SA (1996) Differential expression of integrin a subunits supports distinct roles during lung branching morphogenesis. Developmental Dynamics 206: 169–181.
Xu J and Clark AF (1996) Extracellular matrix alters PDGF regulation of fibroblast integrins. J Cell Biol 132: 230–249.
Yamamoto H, Irie A, Fukushima Y, Ohnishi T, Arita N, Hayakawa T and Sekiguchi K (1996) Abrogation of lung metastasis of human fibrosarcoma cells by ribozyme-mediated suppression of integrin a6 subunit expression. Int J Cancer 65: 519–524.
Yao C-C, Breuss J, Pytela R and Kramer RH (1997) Functional expression of the alpha 7 integrin receptor in differentiated smooth muscle cells. J Cell Sci 110: 1477–1487.
Yebra M, Filardo E, Bayna E, Kawahara J and Cheresh D (1995) Induction of carcinoma cell migration on vitronectin by NF-KB dependent gene expression. Mol Biol Cell 6: 841–850.
Yoshihara T, Hibi S, Tsunamoto K, Todo S and Imashuku S (1997) Increased levels of av-associated integrins associated with growth inhibition of cultured tumor cells by bromodeoxyuridine. Anticanc Res 17: 833–838.
Zhang Z, Tarone G and Turner DC (1993) Expression of integrin aißi is regulated by nerve growth factor and dexamethasone in PC12 cells. J Biol Chem 268 (8): 5557–5565.
Zhang Z, Vuori K, Reed JC and Ruoslahti E (1995) The a5ß1 integrin supports survival of cells on fibronectin and up-regulates bcl-2 expression. Proc Natl Acad Sci USA 92: 6161–6165.
Ziober BL, Lin CS and Kramer RH (1996) Laminin-binding integrins in tumour progression and metastasis. Sem Can Biol 7: 119–128.
Zutter MM, Ryan EE and Painter AD (1997) Binding of phosphorylated Spl protein to tandem Spl binding sites regulates alpha2 integrin gene core promoter activity. Blood 90 (2): 678–689.
Zutter MM, Santoro SA, Painter AS, Tsung YL and Gafford A (1994) The human 02 integrin gene promoter. J Biol Chem 269 (1): 463–469.
Zutter MM, Santoro SA, Staatz WD and Tsung YL (1995) Re-expression of the a2ß1 integrin abrogates the malignant phenotype of breast carcinoma cells. Proc Natl Acad Sci USA 92: 7411–7415.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Daly, N., Meleady, P., Walsh, D., Clynes, M. (1998). Regulation of keratin and integrin gene expression in cancer and drug resistance. In: Clynes, M. (eds) Multiple Drug Resistance in Cancer 2. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-2374-9_22
Download citation
DOI: https://doi.org/10.1007/978-94-017-2374-9_22
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-5108-0
Online ISBN: 978-94-017-2374-9
eBook Packages: Springer Book Archive